As of 2025-09-16, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.38 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.6x - 13.1x | 9.3x |
| Forward P/E multiples | 6.6x - 16.0x | 11.1x |
| Fair Price | (14.80) - (29.18) | (22.74) |
| Upside | -2790.3% - -5405.6% | -4234.3% |
| Date | EV/EBITDA |